Imarx Pharmaceutical Corp.
Records under this name other than patents Imarx Pharmaceutical Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Imarx Pharmaceutical Corp.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,428,630 | Method for coating and protecting a substrate Formerly held Term ended Term ended May 18, 2020 · USPTO record | Term ended | Term ended May 18, 2020 | USPTO record |
| US 6,443,898 | Therapeutic delivery systems Formerly held Term ended Term ended Sep 3, 2019 · USPTO record | Term ended | Term ended Sep 3, 2019 | USPTO record |
| US 6,056,938 | Cationic lipids and the use thereof Formerly held Term ended Term ended May 5, 2018 · USPTO record | Term ended | Term ended May 5, 2018 | USPTO record |
| US 6,033,646 | Method of preparing fluorinated gas microspheres Formerly held Term ended Term ended Feb 19, 2018 · USPTO record | Term ended | Term ended Feb 19, 2018 | USPTO record |
| US 6,548,047 | Thermal preactivation of gaseous precursor filled compositions Formerly held Term ended Term ended Jan 17, 2018 · USPTO record | Term ended | Term ended Jan 17, 2018 | USPTO record |
| US 6,231,834 | Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same Formerly held Term ended Term ended Dec 2, 2017 · USPTO record | Term ended | Term ended Dec 2, 2017 | USPTO record |
| US 6,139,819 | Targeted contrast agents for diagnostic and therapeutic use Formerly held Term ended Term ended Sep 17, 2017 · USPTO record | Term ended | Term ended Sep 17, 2017 | USPTO record |
| US 6,403,056 | Method for delivering bioactive agents using cochleates Formerly held Term ended Term ended Mar 21, 2017 · USPTO record | Term ended | Term ended Mar 21, 2017 | USPTO record |
| US 6,033,645 | Methods for diagnostic imaging by regulating the administration rate of a contrast agent Formerly held Term ended Term ended Jun 19, 2016 · USPTO record | Term ended | Term ended Jun 19, 2016 | USPTO record |
| US 7,612,033 | Methods for delivering compounds into a cell Lapsed on the fee record Ended Nov 3, 2013 · USPTO record | Lapsed on the fee record | Ended Nov 3, 2013 | USPTO record |